Merrion Pharmaceuticals Receives 2008 Frost & Sullivan Osteoporosis Technology Innovation of the Year Award.
Merrion Pharmaceuticals the TCD based Irish American company has confirmed that it has begun a joint feasibility study on oral drug delivery with Swiss based multinational Ferring Pharmaceuticals.
Merrion Pharmaceuticals today announced the continuation of an oral drug delivery research collaboration programme with Novo Nordisk. This follows on from the completion of several oral feasibility studies combining Merrion's Gastrointestinal Permeation Enhancement Technology (GIPET) oral drug delivery technology with Novo Nordisk compounds.
Merrion Pharmaceuticals Plc was admitted to the IEX today and commenced unconditional trading.
Merrion Pharmaceuticals Ltd, Dublin, announced the successful conclusion of an €8m funding round which was oversubscribed, and was managed on behalf of the company by Goodbody Stockbrokers.
Enterprise START Programme
As Enterprise Ireland are anxious to greatly increase the number of High Potential Start-Up Companies, this Programme is heavily subsidised (70%) resulting in a cost per participant of €275
Merrion Pharma raises €5M ahead of 2007 float Dublin drugmaker Merrion Pharma has raised €5M in funding ahead of a dual stock market floatation
Pharma Firm Merrion Hires Funding Adviser Merrion Pharmaceuticals will this week begin a fundraising roadshow in Dublin
Maher appointed MD at bioscience investment specialist Growcorp Bioscience investment specialist Growcorp has appointed Fintan Maher as managing director.
Biopharma Firm Plans Drug Launch
Trinity College based pharmaceuticals start-up Merrion Biopharma said yesterday that it was on track to introduce its products on to the $24 billion (€19.5 billion) oral drug delivery .........
Investing in Ireland
From World Pharmaceutical Frontiers
The Republic of Ireland offers enormous potential to foreign investors for the pharmaceuticals, and particularly the biopharmaceuticals industry.
17/06/2004 Funding of €20m now in sight for new pharma
A new specialty pharmaceutical company backed by the sons of entrepreneur Tony Ryan is close to receiving an estimated €20m-plus in venture capital funding.
06/06/2004 €1.8m funding could finance NeutekBio expansion
NeutekBio, the Galway biotechnology company, plans to expand and bank its first revenues by the end of the year after raising €1.8 million from investors.
01/06/2004 The Growcorp life sciences investment firm run by leading businessman Michael Donnelly, is planning to raise €50 million and …….
30/05/2004 Growcorp in bid for €75m venture capital fund Growcorp, the life sciences investment firm, plans to raise a new €75 million venture capital fund.
May 2004 Ireland – Bio-Incubator Launched Dublin – Ireland is going to boost its biotech sector by investing in building up biotech incubators.
April 2004 South Dublin Chamber of Commerce Year Book John Dunne Ex CEO – Personal Reflection
When I joined the Chamber it was in the process of extending …..
27/03/2004 Elan Sells Projects to Start-Up
Elan has sold a drug-delivery research and development operation based at Trinity College to an Irish start-up, which recently secured $25 million (€20.6 million) in funding....
01/03/2004 Growcorp Establishes Drug Delivery & Biotechnology Company Adaptív Biopharma Limited (“Adaptiv”) is a company established by Growcorp to facilitate the acquisition and licensing of a number of technologies from Elan Corporation...
11/13/2002 Tánaiste launches new €25 million bioscience fund
Mary Harney, Tánaiste and Minister for Enterprise, Trade and Employment, today launched the Growcorp €25 million European Bioscience Fund I – a new seed and venture capital fund...
